English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe new Center will position Ohio as an international leader for research into emerging pathogens and virus-related diseases and will serve as a significant economic catalyst in Northeast Ohio. Funding comes through a $500 million investment from the State of Ohio, JobsOhio and Cleveland Clinic.
“The Cleveland Innovation District creates partnerships across different sectors of the economy and positions Ohio as a competitive place to invest in,” said Governor Mike DeWine. “Each of the Cleveland Innovation District partners bring unique skills and areas of expertise. Having these institutions partner together will help Ohio emerge as a leader in healthcare and IT nationally and globally.”
The State of Ohio and JobsOhio will invest $200 million to help launch the Center and Cleveland Clinic plans an additional $300 million as a co-investment to fuel discoveries in our new and existing research facilities. Further, the Center will create new start-up technology companies in the Cleveland Innovation District, attract world-leading corporations to Ohio, and generate an estimated 1,000 new jobs at Cleveland Clinic by 2029 and an additional 7,500 jobs in Ohio by 2034.
“We are exceedingly grateful to Governor DeWine, Lieutenant Governor Husted, JobsOhio and Ohio Development Service Agency for their extraordinary vision for economic development and research in Ohio,” said Tom Mihaljevic, M.D., President and CEO of Cleveland Clinic. “This is the largest research effort in Cleveland Clinic’s 100-year history. The Global Center for Pathogen Research & Human Health will put Cleveland, Ohio at the forefront of pathogen research and preparing for the next pandemic or health care crisis. The Center will have a significant impact on global health, while creating jobs and educational opportunities in Ohio.”
Headquartered in Cleveland and spanning Cleveland Clinic’s international footprint in Florida, London and Abu Dhabi, the Global Center for Pathogen Research & Human Health will bring together a research team focused on broadening understanding of viral pathogens, virus-induced cancers, genomics, immunology and immunotherapies. It will expand upon Cleveland Clinic’s existing programs and expertise, with newly recruited world leaders in immunology, cancer biology, immune-oncology and pathogen research as well as technology development and education. Researchers will expand critical work on studying, preparing and protecting against public health threats such as HIV/AIDS, Dengue fever, Zika and COVID-19.
“The Global Center for Pathogen Research & Human Health will be a command center to help solve deadly threats to our health, economy and communities,” said Serpil Erzurum, M.D., Cleveland Clinic’s Chief Research and Academic Officer. “The unparalleled investment in the Center will drive workforce development while leveraging Cleveland Clinic’s research infrastructure to study pathogens and the immune system in novel ways to develop new diagnostic tests, vaccines and treatments.”
Cleveland Clinic, with its world-wide clinical and research operations, top scientists and physicians, medical educational programs and international funding, is uniquely positioned to be a global hub for state-of-the-art pathogen research, clinical care and serving as an incubator for rapid development, testing and deployment of diagnostics, medicines and vaccines. The Center is organized around six highly collaborative programs with multidisciplinary experts in virology and immunology; personalized medicine and genomics; population health; drug discovery; diagnostic development and integration of big data with patient care.
The Center is led by Jae Jung, Ph.D., an internationally renowned expert in virology and virus-induced cancers who has broken ground in the field of inflammation, immune-oncology and emerging pathogens. This team plans the recruitment of more than 300 scientists in the next 5-7 years.
The support of JobsOhio will position the Center to thrive not just as a research center but a commercial force that will drive new products, jobs and economic development in Ohio. Working closely with Cleveland Innovation District partner organizations Case Western Reserve University, Cleveland State, The MetroHealth System and University Hospitals, Cleveland Clinic will provide workforce development training for job opportunities as the Center expands.
“Through this unprecedented investment, we will establish educational and career opportunities for Ohioans with the goal of attracting and retaining the very best talent,” said Dr. Erzurum. “A major focus will be training the next generation of Ohio’s workforce for careers that are growing in science, education and health care. We are thrilled to be part of the Cleveland Innovation District which promises to transform Northeast Ohio into an economic engine for biomedicine.”
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Among Cleveland Clinic’s 67,554 employees worldwide are more than 4,520 salaried physicians and researchers, and 17,000 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,026-bed health system that includes a 165-acre main campus near downtown Cleveland, 18 hospitals, more than 220 outpatient facilities, and locations in southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2019, there were 9.8 million total outpatient visits, 309,000 hospital admissions and observations, and 255,000 surgical cases throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/CCforMedia and twitter.com/ClevelandClinic. News and resources available at newsroom.clevelandclinic.org.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
#
